Area of research
Infectious Diseases · Molecular Biology
Research interest
Research focused on Hepatocellular carcinoma and Meta-analysis, with related work in Coronavirus disease 2019 (COVID-19), Meloxicam, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Notable publications include 'Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review', 'Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients', and 'Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review,...'.
Efficacy and safety of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide, a rapid-acting meloxicam formulation, for analgesia after orthopaedic surgery under general anaesthesia: a randomized controlled trial
Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients